Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Silo Pharma (SILO) Shares Outstanding (2019 - 2025)

Silo Pharma (SILO) has disclosed Shares Outstanding for 7 consecutive years, with $13.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 196.99% to $13.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.3 million through Dec 2025, up 196.99% year-over-year, with the annual reading at $13.3 million for FY2025, 196.99% up from the prior year.
  • Shares Outstanding hit $13.3 million in Q4 2025 for Silo Pharma, up from $10.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $100.5 million in Q3 2022 to a low of $227.0 in Q2 2021.
  • Historically, Shares Outstanding has averaged $18.3 million across 5 years, with a median of $3.6 million in 2022.
  • Biggest five-year swings in Shares Outstanding: tumbled 100.0% in 2021 and later surged 44292985.46% in 2022.
  • Year by year, Shares Outstanding stood at $227.0 in 2021, then skyrocketed by 1391572.25% to $3.2 million in 2022, then changed by 0.0% to $3.2 million in 2023, then surged by 41.95% to $4.5 million in 2024, then surged by 196.99% to $13.3 million in 2025.
  • Business Quant data shows Shares Outstanding for SILO at $13.3 million in Q4 2025, $10.5 million in Q3 2025, and $8.7 million in Q2 2025.